340 related articles for article (PubMed ID: 10860896)
1. Using pharmacokinetics to optimize antiretroviral drug-drug interactions in the treatment of human immunodeficiency virus infection.
Gerber JG
Clin Infect Dis; 2000 Jun; 30 Suppl 2():S123-9. PubMed ID: 10860896
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological considerations in antiretroviral therapy.
Sommadossi JP
Antivir Ther; 1998; 3 Suppl 4():9-12. PubMed ID: 10723503
[TBL] [Abstract][Full Text] [Related]
3. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
4. Antiretroviral therapies.
Owen WF
Clin Podiatr Med Surg; 1998 Apr; 15(2):227-39. PubMed ID: 9576051
[TBL] [Abstract][Full Text] [Related]
5. Practical issues regarding the use of antiretroviral therapy for HIV infection.
Deeks SG
West J Med; 1998 Feb; 168(2):133-9. PubMed ID: 9499754
[TBL] [Abstract][Full Text] [Related]
6. Challenges for the clinical development of new nucleoside reverse transcriptase inhibitors for HIV infection.
Wainberg MA; Sawyer JP; Montaner JS; Murphy RL; Kuritzkes DR; Raffi F
Antivir Ther; 2005; 10(1):13-28. PubMed ID: 15751760
[TBL] [Abstract][Full Text] [Related]
7. Acute pancreatitis associated with different combination therapies in patients infected with human immunodeficiency virus.
Guo JJ; Jang R; Louder A; Cluxton RJ
Pharmacotherapy; 2005 Aug; 25(8):1044-54. PubMed ID: 16207094
[TBL] [Abstract][Full Text] [Related]
8. State of the art: antiretroviral and prophylactic treatments in HIV/AIDS.
Porche DJ
Nurs Clin North Am; 1999 Mar; 34(1):95-112. PubMed ID: 9922281
[TBL] [Abstract][Full Text] [Related]
9. Nucleoside analogue-sparing strategy for the treatment of chronic HIV infection: potential interest and clinical experience.
Joly V; Yeni P
Antivir Ther; 2005; 10(1):29-40. PubMed ID: 15751761
[TBL] [Abstract][Full Text] [Related]
10. NNRTI plus PI combinations in the perspective of nucleoside-sparing or nucleoside-failing antiretroviral regimens.
Joly V; Descamps D; Yeni P
AIDS Rev; 2002; 4(3):128-39. PubMed ID: 12416447
[TBL] [Abstract][Full Text] [Related]
11. Cellular factors for resistance against antiretroviral agents.
Fridland A; Connelly MC; Robbins BL
Antivir Ther; 2000 Sep; 5(3):181-5. PubMed ID: 11075937
[TBL] [Abstract][Full Text] [Related]
12. Nevirapine levels after discontinuation of rifampicin therapy and 60-week efficacy of nevirapine-based antiretroviral therapy in HIV-infected patients with tuberculosis.
Manosuthi W; Ruxrungtham K; Likanonsakul S; Prasithsirikul W; Inthong Y; Phoorisri T; Sungkanuparph S
Clin Infect Dis; 2007 Jan; 44(1):141-4. PubMed ID: 17143831
[TBL] [Abstract][Full Text] [Related]
13. Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patients.
Benson CA; Deeks SG; Brun SC; Gulick RM; Eron JJ; Kessler HA; Murphy RL; Hicks C; King M; Wheeler D; Feinberg J; Stryker R; Sax PE; Riddler S; Thompson M; Real K; Hsu A; Kempf D; Japour AJ; Sun E
J Infect Dis; 2002 Mar; 185(5):599-607. PubMed ID: 11865416
[TBL] [Abstract][Full Text] [Related]
14. New antiretroviral drugs, part II: NRTIs, NNRTIs, and beyond.
Murphy RL
AIDS Clin Care; 1999 Jun; 11(6):47-9, 51, 53-4. PubMed ID: 11366882
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 protease inhibitors.
Eron JJ
Clin Infect Dis; 2000 Jun; 30 Suppl 2():S160-70. PubMed ID: 10860901
[TBL] [Abstract][Full Text] [Related]
16. Therapy of HIV infection.
Chang YC; Tyring SK
Dermatol Ther; 2004; 17(6):449-64. PubMed ID: 15571495
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection.
Bozzette SA; Ake CF; Tam HK; Chang SW; Louis TA
N Engl J Med; 2003 Feb; 348(8):702-10. PubMed ID: 12594314
[TBL] [Abstract][Full Text] [Related]
18. The current role of ritonavir-boosted protease inhibitors in the management of HIV infection.
Wilkins E
J HIV Ther; 2008 Mar; 13(1):9-18. PubMed ID: 18953268
[No Abstract] [Full Text] [Related]
19. Elevated plasma concentrations of protease inhibitors and nonnucleoside reverse transcriptase inhibitors in patients coinfected with human immunodeficiency virus and hepatitis B or C: case series and literature review.
Robertson SM; Scarsi KK; Postelnick MJ; Lynch P
Pharmacotherapy; 2005 Aug; 25(8):1068-72. PubMed ID: 16207097
[TBL] [Abstract][Full Text] [Related]
20. Capravirine, a nonnucleoside reverse-transcriptase inhibitor in patients infected with HIV-1: a phase 1 study.
Gewurz BE; Jacobs M; Proper JA; Dahl TA; Fujiwara T; Dezube BJ
J Infect Dis; 2004 Dec; 190(11):1957-61. PubMed ID: 15529260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
